CIK 0001638287 · Non-accelerated filer<br>Smaller reporting company
MetaVia Inc.
Sign in to watch- Ticker
- MTVA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 472389984
- Phone
- (857) 702-9600
- Business address
- 545 CONCORD AVENUE, SUITE 210, CAMBRIDGE, MA, 02138
- Former names
- NeuroBo Pharmaceuticals, Inc., Gemphire Therapeutics Inc.
- 425 Deal Prospectus/Communication re Business Combination
- 8-K Event Shareholder vote results · Other events
- 425 Deal Prospectus/Communication re Business Combination
- 10-Q Report Quarterly Report
- EFFECT Other Notice of Effectiveness
- 424B3 Offering Prospectus
- S-4/A Deal Registration Statement - Business Combination
- CORRESP Other Correspondence Between Filers and SEC Staff
- SEC STAFF LETTER Other SEC Staff Letter Redacted Exhibit
- S-4/A Deal Registration Statement - Business Combination
- 8-K Event Material agreement · Shareholder rights changed · Bylaws or fiscal year change
- 425 Deal Prospectus/Communication re Business Combination
- CORRESP Other Correspondence Between Filers and SEC Staff
- UPLOAD Other SEC-generated Letter
- S-4/A Deal Registration Statement - Business Combination
- 8-K Event Delisting notice · Other events
- 425 Deal Prospectus/Communication re Business Combination
- 8-K Event Executive or director change · Other events
- 425 Deal Prospectus/Communication re Business Combination
- UPLOAD Other SEC-generated Letter
Page 21 of 32 · 634 filings